U.S. Markets open in 83 hrs, 38 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 11,543.55 | -171.63 | -1.47% |
| NASDAQ | 2,367.52 | -44.12 | -1.83% |
| S&P 500 | 1,282.83 | -17.85 | -1.37% |
| Day Low 03:57 PM EDT | 49.27 | |
|---|---|---|
| Day High 09:52 AM EDT | 51.11 |
|
| Range | 1.84 | |
| Volume | 323,148 | |
| 30-Day Avg. Vol. | 307,000 |
|
| Difference | 5.26% | |
| Market Cap. | 727.8 M | |
| Change | -12.36 M | |
| Shares Out. | 14.7 M | |
| Percent Traded | 2.20% | |
| Revenue | 397.58 M | |
| Earnings | 18.68 M | |
| EPS (TTM) | 1.59 |
| 52-Wk Low 5/21/08 | 35.35 | |
|---|---|---|
| 52-Wk High 1/16/08 | 51.60 |
|
| Range | 16.25 | |
| Prev. Close 8/28/08 | 50.29 | |
| Today's Open | 50.51 | |
| Change | 0.44% | |
| Dividend (TTM) | 0.00 | |
| Div. Yield (TTM) | 0.00% |
|
| Beta | 1.3733 | |
| P/E Ratio (TTM) | 31.10 | |
| P/E Ratio (Fwd.) | 21.00 |
When it comes to research and development, few can hold a candle to Kendle International. A leading contract research organization (CRO) for the biotechnology and pharmaceutical industries, the company ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | 0.466 3/31/08 | 0.38 3/31/08 |
-0.086
Missed
|
| Last Quarter | 0.461 6/30/08 | 0.52 6/30/08 |
0.059
Beat
|
| Quarterly - 06/30/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 126.99 M | 397.58 M |
| Gross Profit | 59.82 M | 178.56 M |
| Operating Income | -34.32 M | -118.42 M |
| Net Income | 7.84 M | 18.69 M |
Real-Time Quote
